Category: Interviews
Michael West Discusses AgeX Therapeutics
September 30, 2019
At our 2019 Ending Age-related Diseases conference in New York City, we had the pleasure of speaking with Dr. Michael West, the CEO of AgeX Therapeutics. Dr. West can rightfully
Longevity, Aging, and Life Expectancy
September 17, 2019
Dr. S. Jay Olshansky is a Professor in the School of Public Health at the University of Illinois at Chicago, Research Associate at the Center on Aging at the University
David Sinclair on NMN and Epigenetics
September 10, 2019
Dr. David Sinclair, a Professor of Genetics at Harvard Medical School, is one of the most well-known researchers in the field of rejuvenation, and his lab is the beneficiary of
Kevin Strange Teaches Us About MSI-1436
September 9, 2019
Dr. Kevin Strange is the CEO and co-founder of Novo Biosciences, a biotechnology company focused on regenerating the heart and other organs. We recently had the opportunity to interview him
Sarah Constantin on the Daphnia of Daphnia Labs
August 9, 2019
We recently had the opportunity to catch up with Sarah Constantin, one of the founders of the new biotech startup company Daphnia Labs. The company is developing a new platform
George Church Is Creating Therapies for Dogs
July 23, 2019
Recently, we had the opportunity to interview Professor George Church, a well-known geneticist and rejuvenation expert. Prof. Church’s company, Rejuvenate Bio, will be launching a clinical trial to test a
Telomeres and Telomerase with MarÃa Blasco
July 15, 2019
We had the opportunity to interview one of the speakers, Dr. MarÃa Blasco, during the conference, and we asked her more about her work with telomeres, telomerase therapy, and aging.
Sergey Young and the Longevity Vision Fund
July 4, 2019
We recently had the opportunity to interview Sergey Young, a board member of XPRIZE and the creator of the $100m Longevity Vision Fund. When did you first become interested in
Jerry Shay on Telomere Measurements
April 17, 2019
Professor Jerry Shay of the Shay/Wright lab is perhaps most well-known for his research on telomeres and telomerase and their relation to cancer and aging. He has been instrumental in
Joan Mannick of resTORbio Discusses Rapalogs
April 16, 2019
Rapamycin is a promising anti-aging therapeutic derived from a bacterium that was first found on Easter Island (it’s named for Rapa Nui, the official name of Easter Island). It inhibits
Kelsey Moody & Huda Suliman On Rejuvenation
April 11, 2019
At Undoing Aging 2019, we interviewed some of the best researchers who are involved in discovering therapies for the root causes of aging. Their research aims to ameliorate the damages
Yuri Deigin On Yamanaka Factors
April 5, 2019
At the Undoing Aging 2019 conference, we had the opportunity to interview Yuri Deigin, the CEO of Youthereum Genetics. His company is developing therapies that focus on OSKM, the Yamanaka
Reversing Cellular Aging with Prof. Vittorio Sebastiano
April 4, 2019
We recently attended the Undoing Aging Conference in Berlin and had the opportunity to interview Professor Vittorio Sebastiano of Turn.Bio, a company developing partial cellular reprogramming techniques to reverse cellular
An Interview with Dr. Judith Campisi
April 3, 2019
At Undoing Aging 2019, we interviewed some of the best researchers who are involved in discovering therapies for the root causes of aging. Their research aims to ameliorate the damages
Building a Company to End Age-Related Diseases
February 12, 2019
I recently visited the Longevity Leaders Conference in London and had the opportunity to speak with Kelsey Moody, the CEO of Ichor Therapeutics, a company focused on targeting age-related diseases
Michael West Discusses AgeX Therapeutics
September 30, 2019
At our 2019 Ending Age-related Diseases conference in New York City, we had the pleasure of speaking with Dr. Michael West, the CEO of AgeX Therapeutics. Dr. West can rightfully be called a pioneer in his field with a substantial background in biomedical and biotechnology corporations.
Longevity, Aging, and Life Expectancy
September 17, 2019
Dr. S. Jay Olshansky is a Professor in the School of Public Health at the University of Illinois at Chicago, Research Associate at the Center on Aging at the University of Chicago and at the London School of Hygiene and Tropical Medicine, and Chief Scientist at
David Sinclair on NMN and Epigenetics
September 10, 2019
Dr. David Sinclair, a Professor of Genetics at Harvard Medical School, is one of the most well-known researchers in the field of rejuvenation, and his lab is the beneficiary of a successful Lifespan.io campaign. Today, Dr. Sinclair is releasing his book on Amazon, “Lifespan: Why We
Kevin Strange Teaches Us About MSI-1436
September 9, 2019
Dr. Kevin Strange is the CEO and co-founder of Novo Biosciences, a biotechnology company focused on regenerating the heart and other organs. We recently had the opportunity to interview him about MSI-1436 (trodusquemine), a compound that promotes regeneration in multiple animal models. What, if anything, happens
Sarah Constantin on the Daphnia of Daphnia Labs
August 9, 2019
We recently had the opportunity to catch up with Sarah Constantin, one of the founders of the new biotech startup company Daphnia Labs. The company is developing a new platform for the discovery of geroprotective drugs: in vivo phenotypic screens in model organisms. The company plans
George Church Is Creating Therapies for Dogs
July 23, 2019
Recently, we had the opportunity to interview Professor George Church, a well-known geneticist and rejuvenation expert. Prof. Church’s company, Rejuvenate Bio, will be launching a clinical trial to test a rejuvenation therapy in dogs this fall. In your recent paper on enabling large-scale genome editing, you
Telomeres and Telomerase with MarÃa Blasco
July 15, 2019
We had the opportunity to interview one of the speakers, Dr. MarÃa Blasco, during the conference, and we asked her more about her work with telomeres, telomerase therapy, and aging. Telomere loss is a proposed reason we age Telomere attrition—the wearing out of your chromosomes’ protective
Sergey Young and the Longevity Vision Fund
July 4, 2019
We recently had the opportunity to interview Sergey Young, a board member of XPRIZE and the creator of the $100m Longevity Vision Fund. When did you first become interested in healthy life extension, and why? My interest began with a routine visit to a doctor. Five
Jerry Shay on Telomere Measurements
April 17, 2019
Professor Jerry Shay of the Shay/Wright lab is perhaps most well-known for his research on telomeres and telomerase and their relation to cancer and aging. He has been instrumental in the development of telomerase inhibitors, which turn off the expression of telomerase in cancer cells; this
Joan Mannick of resTORbio Discusses Rapalogs
April 16, 2019
Rapamycin is a promising anti-aging therapeutic derived from a bacterium that was first found on Easter Island (it’s named for Rapa Nui, the official name of Easter Island). It inhibits mTOR (mechanistic target of rapamycin), thus inhibiting the immune system response that would, in some cases,
Kelsey Moody & Huda Suliman On Rejuvenation
April 11, 2019
At Undoing Aging 2019, we interviewed some of the best researchers who are involved in discovering therapies for the root causes of aging. Their research aims to ameliorate the damages of aging and may one day lead to a future without the diseases of aging. We
Yuri Deigin On Yamanaka Factors
April 5, 2019
At the Undoing Aging 2019 conference, we had the opportunity to interview Yuri Deigin, the CEO of Youthereum Genetics. His company is developing therapies that focus on OSKM, the Yamanaka factors known for turning cells back into a pluripotent state. By partially reprogramming cells using a
Reversing Cellular Aging with Prof. Vittorio Sebastiano
April 4, 2019
We recently attended the Undoing Aging Conference in Berlin and had the opportunity to interview Professor Vittorio Sebastiano of Turn.Bio, a company developing partial cellular reprogramming techniques to reverse cellular aging. As we age, our cells experience changes to their epigenetic markers, and this, in turn,
An Interview with Dr. Judith Campisi
April 3, 2019
At Undoing Aging 2019, we interviewed some of the best researchers who are involved in discovering therapies for the root causes of aging. Their research aims to ameliorate the damages of aging and may one day lead to a future without age-related diseases. Dr. Judith Campisi,
Building a Company to End Age-Related Diseases
February 12, 2019
I recently visited the Longevity Leaders Conference in London and had the opportunity to speak with Kelsey Moody, the CEO of Ichor Therapeutics, a company focused on targeting age-related diseases by targeting the aging processes themselves. I previously interviewed him back in 2017, so it was